A detailed retrospective study of 872 patients with SDHx PGVs found a much lower risk of metastatic disease at 4.2% (95% CI 1.1–7.2%) by age 60 in non-proband SDHB PGV carriers (Andrews et al. 2018). The gene discussed is SDHB; the disease is metastatic neoplasm.